Considering Race and Ancestry in Precision Approaches to Cancer Care
Most medical professionals have insufficient knowledge about the role that precision medicine has in clinical practice. Genetic alterations affect all types of cancer and often affect cardiovascular, autoimmune, and neurological diseases. Laboratory tools used in precision medicine are highly sophisticated and include genomics, proteomics, and other high-dimensional assays. The series will provide regular updates on these tools, the ways the tools could improve patient care, and the ethical and legal issues surrounding genetic testing. The series will also examine how testing for genetically influenced diseases can affect personalized management of individuals and their families.
Physicians, residents, fellows, medical students, nurses, and other health professionals.
At the conclusion of the session, the participants should be able to:
Demonstrate greater understanding of cancer disparities and how they are related to population groups often defined by health disparities.
Identify racial groups most often affected by cancer disparities.
Distinguish race from genetic ancestry.
Recognize how not considering race and/or ancestry affects precision medicine approaches to cancer diagnosis and treatment.
Baylor College of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Baylor College of Medicine designates this enduring material activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This activity has been designated by Baylor College of Medicine for 1 credit of education in medical ethics and/or professional responsibility.
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Ethics
- 1.00 Participation